CIK 0002079109 · <br>Emerging growth company
Veraxa Biotech AG - Post de-SPAC
Sign in to watch- Ticker
- VRXA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41443858450
- Business address
- TALACKER 35, ZURICH, Switzerland, 8001
- Former names
- Veraxa Biotech Holding AG
Securities
- VRXA Ordinary Shares Nasdaq
- VRXAW Warrants Nasdaq
- Open-market buys, last 90 days
- $125,333
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$125,333. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-28 | Gruninger Marc Director | Purchase | +9,133 | $1.00 | $9K | 10,000 |
| 2026-10-27 | Gruninger Marc Director | Purchase | +867 | $0.98 | $850 | 867 |
| 2026-10-20 | Ziegler Christoph Samuel Director | Purchase | +30,000 | $1.09 | $33K | 37,932 |
| 2026-08-27 | Baumann Oliver Rolf Director | Purchase | +50,000 | $1.50 | $75K | 5,773,618 |
| 2026-08-27 | Antz Christoph Rudiger Chief Executive Officer | Purchase | +5,000 | $1.53 | $8K | 5,000 |
Page 1 of 1 · 5 trades